Ilhan Celik
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Oncology 8
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Eric Van Cutsem (6 shared papers)Michael Schlichting (4 shared papers)Fortunato Ciardiello (3 shared papers)Philippe Rougier (2 shared papers)Sabine Tejpar (3 shared papers)Carsten Bokemeyer (3 shared papers)Stefano Cascinu (1 shared paper)I. Shchepotin (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)The Lancet Oncology (3 papers)World Journal of Surgery (3 papers)European Journal of Cancer (2 papers)International Journal of Colorectal Disease (1 paper)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Ilhan Celik
31 papers receiving 3.8k citations
Ilhan Celik's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 2.3k
- Hepatology 384
- Pulmonary and Respiratory Medicine 1.2k
- Pathology and Forensic Medicine 633
- Cancer Research 481
Countries citing papers authored by Ilhan Celik
This map shows the geographic impact of Ilhan Celik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilhan Celik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilhan Celik more than expected).
Fields of papers citing papers by Ilhan Celik
This network shows the impact of papers produced by Ilhan Celik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilhan Celik. The network helps show where Ilhan Celik may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilhan Celik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status Hit paper breakdown → | 2011 | 1445 |
| 2 | Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial Hit paper breakdown → | 2013 | 626 |
| 3 | EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study Hit paper breakdown → | 2011 | 455 |
| 4 | Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials Hit paper breakdown → | 2012 | 447 |
| 5 | 2012 | 287 | |
| 6 | 2012 | 118 | |
| 7 | 2005 | 112 | |
| 8 | 2005 | 110 | |
| 9 | 2007 | 49 | |
| 10 | 2005 | 40 | |
| 11 | 2003 | 32 | |
| 12 | 2001 | 32 | |
| 13 | 2002 | 17 | |
| 14 | 2004 | 15 | |
| 15 | 2006 | 14 | |
| 16 | 2012 | 13 | |
| 17 | 2023 | 10 | |
| 18 | 2005 | 10 | |
| 19 | 2024 | 9 | |
| 20 | 2011 | 9 |
About Ilhan Celik
Ilhan Celik is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Biotechnology, having authored 32 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Research and Treatments (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Sepsis Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (2.3k citations), Hepatology (384 citations), Pulmonary and Respiratory Medicine (1.2k citations), Pathology and Forensic Medicine (633 citations) and Cancer Research (481 citations). Ilhan Celik has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Eric Van Cutsem, Michael Schlichting, Fortunato Ciardiello, Philippe Rougier, Sabine Tejpar, Carsten Bokemeyer, Stefano Cascinu, I. Shchepotin, Marek P. Nowacki and István Láng. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, World Journal of Surgery, European Journal of Cancer and International Journal of Colorectal Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.